共 32 条
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report
被引:1
|作者:
Lococo, F.
[1
]
Di Giorgio, A.
[2
]
Iaffaldano, A.
[1
]
Schinzari, G.
[3
]
Tabacco, D.
[1
]
Aceto, P.
[4
]
Abatini, C.
[2
]
Sollazzi, L.
[4
]
Margaritora, S.
[1
]
机构:
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Unit Thorac Surg, IRCCS, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, IRCCS, Gen Surg, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Oncol Unit, IRCCS, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Anaesthesiol Unit, IRCCS, Rome, Italy
关键词:
Chemotherapy;
Hyperthermic;
Psedomixoma;
Intrathoracic chemotherapy;
PSEUDOMYXOMA PERITONEI;
D O I:
10.26355/eurrev_202101_24403
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Pseudomyxoma peritonei (PMP) is an uncommon disease with locally-invasive attitude. Intrathoracic spread is rarely reported and its management extremely challenging. A 51-year-old Caucasian female presented with left pleural carcinosis 9-months after two sequential abdominal surgical procedures combined with HIPEC for low-grade PMP. Cytoreductive surgery (pleurectomy/decortication) was followed by 60-minutes hyperthermic intrathoracic chemotherapy mitomycin-C (215 mg/m2) infusing at same temperature (42 degrees C) and intrapleural pression (2-4 mm(H)20). No intra-operative complication occurred, the post-op stay was uneventful and no sign of recurrence was observed 9-months after surgery. Cytoreductive thoracic surgery and hyperthermic chemotherapy (HITHOC) could be a feasible therapeutic option in very selected cases.
引用
收藏
页码:362 / 365
页数:4
相关论文